The histologic damage in the colitis-inducing agent, dextran sulfate sodium (DSS)-treated Muc2-deficient mice are different compared with wild type and Muc2-heterozygous deficient mice, with many crypt abscesses [8]. This evidence concerns the gene MUC2 and abscess.